Beijing New Oriental Star Petrochemical Engineering Co Ltd

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, produces, and sells active pharmaceutical ingredients and formulations in China. Its digestive health products include pump inhibitors for conditions such as peptic ulcers, reflux esophagitis, and upper gastrointestinal bleeding. It also offers anti-tumor products for non-small cell lung cancer, colorectal cancer, and breast cancer, covering targeted therapy, chemotherapy, endocrine therapy, and adjuvant medications. In addition, the company provides anti-infective products against bacterial and invasive fungal infections, and products for chronic diseases requiring long-term management, including diabetes, osteoarthritis, thrombocytopenia, and iron overload. Founded in 1996, the company is based in Nanjing, China.